MiR-21-5p was expected to target 12 key genes involved in DKD, e.g., DGKH, DDAH1, DNM1L, PPARGC1A, STAT5, THBS1, and SPARC [31]. This evidence concerns the gene PPARGC1A and diabetic kidney disease.